South Koreas FDA cracks down on fake 1 egg labels amid consumer deception South Koreas regulators take significant measures ...

Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).

Generally, the FDA approval review period is 10 months ... Winter increases heart attack and stroke risks for seniors in Korea If you suddenly experience dizziness and headaches, or if you ...

Celltrion announced on Friday that its biosimilar Avtozma, a version of the autoimmune disease treatment Actemra (active ingredient tocilizumab), has received product approval from the US Food and ...

WASHINGTON, D.C. — The Food and Drug Administration (FDA) has issued a recall notice for 3.52-ounce packages of Shirakiku ...

The FDA has issued a complete response letter (CRL) to Spectrum Pharma for poziotinib, its pan HER2 inhibitor for a form of lung cancer, according to South Korea's Hanmi Pharma, which originally ...

CellBion plans to build on its progress by filing an IND with the Korean FDA. Based on data generated to date, CellBion thinks 177Lu-DGUL may have superior efficacy and fewer side effects ...

The QuickFinder COVID-19/Flu Antigen Self-Test and the QuickFinder COVID-19/Flu Antigen Pro Test detect SARS-CoV-2, influenza A, and influenza B in swab specimens and provide results within 15 minutes ...